Search Results - "ARNONE, Marc R"
-
1
Dabrafenib; preclinical characterization, increased efficacy when combined with trametinib, while BRAF/MEK tool combination reduced skin lesions
Published in PloS one (03-07-2013)“…Mitogen-Activated Protein Kinase (MAPK) pathway activation has been implicated in many types of human cancer. BRAF mutations that constitutively activate MAPK…”
Get full text
Journal Article -
2
Discovery of Dabrafenib: A Selective Inhibitor of Raf Kinases with Antitumor Activity against B‑Raf-Driven Tumors
Published in ACS medicinal chemistry letters (14-03-2013)“…Hyperactive signaling of the MAP kinase pathway resulting from the constitutively active B-RafV600E mutated enzyme has been observed in a number of human…”
Get full text
Journal Article -
3
Synthesis and Biological Evaluation of 1-Aryl-4,5-dihydro-1H-pyrazolo[3,4-d]pyrimidin-4-one Inhibitors of Cyclin-Dependent Kinases
Published in Journal of medicinal chemistry (18-11-2004)“…Using a high-throughput screening strategy, a series of 1-aryl-4,5-dihydro-1H-pyrazolo[3,4-d]pyrimidin-4-ones was identified that inhibit the cyclin-dependent…”
Get full text
Journal Article -
4
Development of potent B-RafV600E inhibitors containing an arylsulfonamide headgroup
Published in Bioorganic & medicinal chemistry letters (01-08-2011)“…A potent series of inhibitors against the B-Raf(V600E) kinase have been developed that show excellent activity in cellular assays and good oral bioavailability…”
Get full text
Journal Article -
5
Putative identification of functional interactions between DNA intercalating agents and topoisomerase II using the V79 in vitro micronucleus assay
Published in Mutation research (19-06-2002)“…Clastogenicity is frequently observed following treatment of mammalian cells with new chemical entities. This clastogenicity, unless proven otherwise, is…”
Get more information
Journal Article -
6
Development of potent B-Raf super(V600E inhibitors containing an arylsulfonamide headgroup)
Published in Bioorganic & medicinal chemistry letters (01-08-2011)“…A potent series of inhibitors against the B-Raf super(V600E kinase have been developed that show excellent activity in cellular assays and good oral…”
Get full text
Journal Article -
7
Development of potent B-Raf V600E inhibitors containing an arylsulfonamide headgroup
Published in Bioorganic & medicinal chemistry letters (2011)“…A potent series of inhibitors against the B-Raf V600E kinase have been developed that show excellent activity in cellular assays and good oral bioavailability…”
Get full text
Journal Article -
8
-
9